Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELOTUZUMAB for Bone lesion: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where ELOTUZUMAB was used for Bone lesion.

Most Reported Side Effects for ELOTUZUMAB

Side Effect Reports % Deaths Hosp.
Plasma cell myeloma 339 9.9% 122 82
Death 234 6.8% 234 10
Malignant neoplasm progression 227 6.6% 88 77
Pneumonia 209 6.1% 58 164
Pyrexia 183 5.3% 35 136
Drug ineffective 137 4.0% 15 26
Neutropenia 133 3.9% 28 69
Anaemia 119 3.5% 36 66
Thrombocytopenia 107 3.1% 17 51
Diarrhoea 105 3.1% 23 47
Fatigue 95 2.8% 17 19
Off label use 93 2.7% 14 26
Sepsis 86 2.5% 50 68
Platelet count decreased 82 2.4% 20 37
Febrile neutropenia 68 2.0% 21 49

Other Indications for ELOTUZUMAB

Plasma cell myeloma (2,659) Product used for unknown indication (703) Plasma cell myeloma refractory (138) Disease progression (9) Plasma cell myeloma recurrent (9) Immunosuppressant drug therapy (5)

Other Drugs Used for Bone lesion

DENOSUMAB (157) ZOLEDRONIC ACID (79) CYCLOPHOSPHAMIDE (18) DEXAMETHASONE (16) BORTEZOMIB (13) LENALIDOMIDE (13) PAMIDRONATE (10) POMALIDOMIDE (10) BELANTAMAB MAFODOTIN (9) DARATUMUMAB (9)

Related Pages

ELOTUZUMAB Full Profile All Bone lesion Drugs ELOTUZUMAB Demographics ELOTUZUMAB Timeline